Pages

Search This Website

May 15, 2021

This drug of DRDO will work as 'Oxygen' for Corona patients

 This drug of DRDO will work as 'Oxygen' for Corona patients, find out when it will be launched



DRDO officials said on Friday that the first batch of 10,000 doses of the 2-DG drug for the treatment of 19 Kovid patients would arrive early next week and that the dose would be given to patients.

This drug of DRDO will work as 'Oxygen' for Corona patients
 This drug of DRDO will work as 'Oxygen' for Corona patients


Fighting the second wave of the Coronavirus epidemic, India will now be able to fight it more vigorously than before. The new drug 2-DG, developed by DRDO to treat Covid 19 patients, is going to be launched soon. In trials, the drug has been shown to have an effective effect against covid, although this covid may prove to be a game-changer in the treatment of patients.


Dependence on oxygen will bring scarcity


DRDO officials said on Friday that the first batch of 10,000 doses of the 2-DG drug for the treatment of 19 Kovid patients would arrive early next week and that the dose would be given to patients. This will not only help patients recover faster from the drug but also work on their oxygen dependence. Tests have shown that patients with this drug lost their oxygen 3 days ago.


"Drug manufacturers are also working to speed up the use of this drug," DRDO officials said. The drug has been developed by a team of DRDO scientists, including Dr. Anant Narayan Bhatt.


The Oxycare system will be purchased with the PM Care Fund

આ માહિતી ગુજરાતી મા વાંચવા અહિ ક્લિક કરો

Karnataka Health Minister Dr. K Sudhakar visited the DRDO premises and learned about 2-DG medicine. It said 1.5 lakh units of Oxycare system would be procured from DRDO at a cost of Rs 322.5 crore from the PM-CARES fund. The Oxycare system eliminates the need for constant measurement of oxygen flow and the need to adjust it manually. It also reduces the risk for patients and hospital staff.


Let me tell you that the anti-covid 19 drug 2-DOXI-D-Glucose (2-DG) was developed in a DRDO laboratory by Nuclear Medicine and Allied Sciences (INMAS) from Dr. Reddy's Laboratories, Hyderabad. Is.

For Best View Please Open This Website In CHROME / OPERA Browser

No comments:

Post a Comment